-
1.发明授权Natural formulation for the treatment and prevention of depression, containing St. John's Wort and derivatives of dihydro- and tetrahydrofolic acid 失效用于治疗和预防抑郁症的天然制剂，含有圣约翰草和二氢和四氢叶酸的衍生物公开(公告)号：US07014865B1
公开(公告)日：2006-03-21
申请号：US09807401
申请日：1999-10-08
Applicant: Herwig Buchholz , Angela Dudda , Jerzy Meduski
Inventor： Herwig Buchholz , Angela Dudda , Jerzy Meduski
CPC classification number: A61K31/525 , A61K36/38 , A61K2300/00
Abstract: The present invention relates to novel compositions containing a combination of the plant St. John's Wort (Hypericum perforatum L.), its extracts of active ingredients and derivatives of dihydro- and tetrahydrofolic acid. This natural formulation is useful for the treatment and prevention of depression with a better effect than the ingredient compounds alone.
Abstract translation: 本发明涉及含有植物圣约翰草（Hypericum perforatum L.），其活性成分提取物和二氢和四氢叶酸衍生物的组合的新型组合物。 这种天然制剂对于治疗和预防抑郁症比单独使用成分化合物具有更好的效果是有用的。
-
![3-[4-(PHENYLAMINOOXALYLAMINO)PHENYL]HEX-4-YNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT](/abs-image/US/2013/07/04/US20130172248A1/abs.jpg.150x150.jpg)
2.发明申请3-[4-(PHENYLAMINOOXALYLAMINO)PHENYL]HEX-4-YNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT 审中-公开3- [4-（苯甲酰氨基氨基）苯基]十六烷基-4-氨基酸，其制备方法和用作药物公开(公告)号：US20130172248A1
公开(公告)日：2013-07-04
申请号：US13734413
申请日：2013-01-04
Applicant: Elisabeth DEFOSSA , Viktoria DIETRICH , Thomas KLABUNDE , Stefanie KEIL , Siegfried STENGELIN , Guido HASCHKE , Andreas HERLING , Johanna KUHLMANN-GOTTKE , Stefan BARTOSCHEK , Simon GESSLER , Angela DUDDA , Guenter BILLEN , Thomas OLPP , Joerg RIEKE-ZAPP
Inventor： Elisabeth DEFOSSA , Viktoria DIETRICH , Thomas KLABUNDE , Stefanie KEIL , Siegfried STENGELIN , Guido HASCHKE , Andreas HERLING , Johanna KUHLMANN-GOTTKE , Stefan BARTOSCHEK , Simon GESSLER , Angela DUDDA , Guenter BILLEN , Thomas OLPP , Joerg RIEKE-ZAPP
IPC: C07C233/56 , A61K38/28 , C07C231/02 , C07C229/42 , A61K31/196 , A61K45/06
CPC classification number: C07C233/56 , A61K31/196 , A61K38/28 , A61K45/06 , C07C229/42 , C07C231/02 , A61K2300/00
Abstract: The invention relates to 3-[4-(phenylaminooxalylamino)phenyl]hex-4-ynoic acids, and to physiologically compatible salts thereof.The invention relates to compounds of the formula I in which R1, R2, R3 and R4 are each defined as specified, and to physiologically compatible salts thereof. The compounds are suitable, for example, for treatment of diabetes.
Abstract translation: 本发明涉及3- [4-（苯基氨基草酰氨基）苯基]己-4-炔酸，以及其生理上相容的盐。 本发明涉及式Ⅰ化合物，其中R 1，R 2，R 3和R 4各自定义和其生理上相容的盐。 该化合物适用于例如治疗糖尿病。
-
Search Results
2
records
(took 0.009 seconds)
